Cargando…
Rapamycin, proliferation and geroconversion to senescence
Rapamycin inhibits cell proliferation, yet preserves (re)-proliferative potential (RPP). RPP is a potential of quiescent cells that is lost in senescent cells. mTOR drives conversion from quiescence to senescence (geroconversion). By suppressing geroconversion, rapamycin preserves RPP. Geroconversio...
Autor principal: | Blagosklonny, Mikhail V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343718/ https://www.ncbi.nlm.nih.gov/pubmed/30541374 http://dx.doi.org/10.1080/15384101.2018.1554781 |
Ejemplares similares
-
S6K in geroconversion
por: Leontieva, Olga V, et al.
Publicado: (2013) -
Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion
por: Leontieva, Olga V., et al.
Publicado: (2014) -
Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program)
por: Leontieva, Olga V., et al.
Publicado: (2015) -
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: Duration of cell cycle arrest and MTOR activity determine geroconversion
por: Leontieva, Olga V, et al.
Publicado: (2013) -
Cancer prevention with rapamycin
por: Blagosklonny, Mikhail V.
Publicado: (2023)